ISSUES AND CHALLENGES IN THE SECTOR

The health sector is at the heart of current debates with this pandemic which has triggered numerous emergency plans. Of course, this pandemic risk must be put into perspective with the many other challenges facing the sector: an ageing population, dependency, an increase in chronic diseases, inequality of access to care, humanitarian issues, etc.

In this context of growing demand and in order to meet the new expectations of patients and users, the ambitious recovery plans implemented will allow the reconfiguration of organisations, services, technical platforms, reception and accommodation structures, digital solutions, environmental approaches, etc.
At the same time, advances in research and the development of new treatments have been greatly enriched and accelerated in recent years. Whether in terms of diagnosis (very high performance imaging, interfacing with Artificial Intelligence and Big Data, continuous collection and monitoring of patients' physiological data, decoding of DNA, connected health, etc. ), the proposed therapeutic arsenal (Innovative Therapy Medicines, Immunotherapy, DNA sequencing, new chemo- and radio-therapies, tailor-made medicines, nanotechnologies, new molecules and modes of action on cells, regenerative medicine, messenger RNA,... ), or techniques and methods of implementation (new surgical techniques and new medical devices, robotisation and miniaturisation of interventions, ambulatory or remote treatments, hyperspecialisation of surgeons/operating blocks and densification of flows, combination of invasive methods and alternative medicine, automation and adaptation of central pharmacies to the patient ), these advances require the hospital world to evolve in depth, both in terms of the transition from curative to preventive (and predictive) medicine, and in terms of the means and infrastructures that it must henceforth have.